跳至主要内容
临床试验/NCT04958629
NCT04958629Unknown不适用

A Prospective Cohort Study on Familial Hypercholesterolemia in Health Examination Population

Peking University Third Hospital0 个研究点目标入组 318 人开始时间: 2021年10月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
318
主要终点
Number of participants with atherosclerotic cardiovascular disease (ASCVD) events

研究概览

简要总结

To determine the prevalence and the prognosis in a corhort of patients with familial hypercholesterolemia (FH).

详细描述

This study aims to achieve the following goals through prospective cohort study and statistical analysis: (1) to determine the prevalence of familial hypercholesterolemia (FH) in healthy people with hypercholesterolemia.(2) Compared with non FH population, the relative risk of atherosclerotic cardiovascular disease (ASCVD) in FH patients in China was calculated, and the risk prediction model of ASCVD in FH patients was constructed by using biochemical results, imaging data, biomarkers and other indicators.(3) To evaluate the benefits of different lipid-lowering strategies for FH patients in China.(4) To analyze the gene carriers of FH patients in China.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with definite diagnosis of hyperlipidemia.

排除标准

  • Do not agree to participate in this study.
  • secondary hypercholesterolemia.
  • Phytosteronemia.

结局指标

主要结局

Number of participants with atherosclerotic cardiovascular disease (ASCVD) events

时间窗: 2 years from enrollmet

1) Fatal or non-fatal myocardial infarction; 2) Fatal or non-fatal ischemic stroke; 3) Coronary artery revascularization; 4) Peripheral artery revascularization; 5) Cardiogenic death

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验